Cargando…

Evaluation of the Optimal Manufacturing Protocols and Therapeutic Properties of Mesenchymal Stem/Stromal Cells Derived from Wharton’s Jelly

Wharton’s jelly (WJ) from the umbilical cord (UC) is a good source of mesenchymal stem/stromal cells (MSCs), which can be isolated and used in therapy. Current knowledge shows that even small changes in the cell environment may result in obtaining a subpopulation of cells with different therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sypecka, Monika, Bzinkowska, Aleksandra, Sulejczak, Dorota, Dabrowski, Filip, Sarnowska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820979/ https://www.ncbi.nlm.nih.gov/pubmed/36614096 http://dx.doi.org/10.3390/ijms24010652

Ejemplares similares

Effects of maternal obesity on Wharton’s Jelly mesenchymal stromal cells
por: Badraiq, Heba, et al.
Publicado: (2017)

Neuroprotective Potential and Paracrine Activity of Stromal Vs. Culture-Expanded hMSC Derived from Wharton Jelly under Co-Cultured with Hippocampal Organotypic Slices
por: Dabrowska, Sylwia, et al.
Publicado: (2017)

Interaction between Macrophages and Human Mesenchymal Stromal Cells Derived from Bone Marrow and Wharton’s Jelly—A Comparative Study
por: Dymowska, Marta, et al.
Publicado: (2021)

The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019)

Promising Markers in the Context of Mesenchymal Stem/Stromal Cells Subpopulations with Unique Properties
por: Smolinska, Agnieszka, et al.
Publicado: (2023)

Biomimetic microenvironmental preconditioning enhance neuroprotective properties of human mesenchymal stem cells derived from Wharton's Jelly (WJ-MSCs)
por: Lech, Wioletta, et al.
Publicado: (2020)

Wharton’ jelly mesenchymal stromal cell therapy for ischemic brain injury
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Concise Review: Wharton's Jelly: The Rich, but Enigmatic, Source of Mesenchymal Stromal Cells
por: Davies, John E., et al.
Publicado: (2017)

Compliance with Good Manufacturing Practice in the Assessment of Immunomodulation Potential of Clinical Grade Multipotent Mesenchymal Stromal Cells Derived from Wharton’s Jelly
por: Grau-Vorster, Marta, et al.
Publicado: (2019)

The Treasury of Wharton's Jelly
por: Guenther, Rebecca, et al.
Publicado: (2021)

Wharton’s Jelly-Derived Mesenchymal Stem Cells: Phenotypic Characterization and Optimizing Their Therapeutic Potential for Clinical Applications
por: Kim, Dae-Won, et al.
Publicado: (2013)

An optimized procedure for preparation of conditioned medium from Wharton’s jelly mesenchymal stromal cells isolated from umbilical cord
por: Acuto, Santina, et al.
Publicado: (2023)

Therapeutic Potential of Wharton’s Jelly Mesenchymal Stem Cells for Diabetes: Achievements and Challenges
por: Kamal, Mohamed M., et al.
Publicado: (2020)

Wharton’s Jelly Mesenchymal Stromal Cells and Derived Extracellular Vesicles as Post-Myocardial Infarction Therapeutic Toolkit: An Experienced View
por: Muñoz-Domínguez, Noelia, et al.
Publicado: (2021)

Wharton’s Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host Disease
por: McGuirk, Joseph P., et al.
Publicado: (2015)

Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application
por: Cabrera-Pérez, Raquel, et al.
Publicado: (2019)

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury
por: Chudickova, Milada, et al.
Publicado: (2019)

AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019)

Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton’s jelly mesenchymal stromal cells
por: Rengasamy, Mathiyazhagan, et al.
Publicado: (2017)

Molecular and Functional Verification of Wharton’s Jelly Mesenchymal Stem Cells (WJ-MSCs) Pluripotency
por: Musiał-Wysocka, Aleksandra, et al.
Publicado: (2019)

Evaluation of HLA-G Expression in Multipotent Mesenchymal Stromal Cells Derived from Vitrified Wharton’s Jelly Tissue
por: Mallis, Panagiotis, et al.
Publicado: (2018)

Neuroprotective Action of Human Wharton’s Jelly-Derived Mesenchymal Stromal Cell Transplants in a Rodent Model of Stroke
por: Wu, Kuo-Jen, et al.
Publicado: (2018)

Efficient Non-Viral Gene Modification of Mesenchymal Stromal Cells from Umbilical Cord Wharton’s Jelly with Polyethylenimine
por: Ramos-Murillo, Ana Isabel, et al.
Publicado: (2020)

Biofabrication of a Tubular Model of Human Urothelial Mucosa Using Human Wharton Jelly Mesenchymal Stromal Cells
por: Garzón, Ingrid, et al.
Publicado: (2021)

Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)

Effects of Wharton’s jelly-derived mesenchymal stem cells on neonatal neutrophils
por: Khan, Imteyaz, et al.
Publicado: (2014)

Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015)

Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion
por: Witkowska-Zimny, Malgorzata, et al.
Publicado: (2011)

Isolation and Characterization of Feline Wharton’s Jelly-Derived Mesenchymal Stem Cells
por: Seo, Min-Soo, et al.
Publicado: (2021)

Assessment of the Neuroprotective and Stemness Properties of Human Wharton’s Jelly-Derived Mesenchymal Stem Cells under Variable (5% vs. 21%) Aerobic Conditions
por: Tomecka, Ewelina, et al.
Publicado: (2021)

Mesenchymal Stem/Stromal Cell Production Compliant with Good Manufacturing Practice: Comparison between Bone Marrow, the Gold Standard Adult Source, and Wharton’s Jelly, an Extraembryonic Source
por: Laroye, Caroline, et al.
Publicado: (2019)

Increased Proliferation and Analysis of Differential Gene Expression in Human Wharton's Jelly-derived Mesenchymal Stromal Cells under Hypoxia
por: Nekanti, Usha, et al.
Publicado: (2010)

Identifying Biomarkers of Wharton’s Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect
por: Laflaquière, Benoît, et al.
Publicado: (2018)

Xeno-Free Human Wharton’s Jelly Mesenchymal Stromal Cells Maintain Their Characteristic Properties after Long-Term Cryopreservation
por: Mathen, Caroline, et al.
Publicado: (2021)

Shipping Temperature, Time and Media Effects on Equine Wharton’s Jelly and Adipose Tissue Derived Mesenchymal Stromal Cells Characteristics
por: Iacono, Eleonora, et al.
Publicado: (2022)

Mesenchymal Stem Cells from the Wharton’s Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential
por: Marino, Luigi, et al.
Publicado: (2019)

Wharton’s jelly mesenchymal stem cells promote wound healing and tissue regeneration
por: Kamolz, Lars-Peter, et al.
Publicado: (2014)

Wharton's Jelly human Mesenchymal Stem Cell contact guidance by noisy nanotopographies
por: Jacchetti, E., et al.
Publicado: (2014)

Differentiation of Wharton's Jelly Derived Mesenchymal Stem Cells into Insulin Producing Cells
por: Ranjbaran, Hossein, et al.
Publicado: (2018)

Evaluating the Differential Effects of Valproic Acid on Wharton’s Jelly Mesenchymal Stem Cells
por: Salami, Homa, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9plpf35sdcluln8cg162m2pcg9